Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Aug;101(2):284–287. doi: 10.1111/j.1365-2249.1995.tb08352.x

The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin.

K Ueda 1, H Nakajima 1, T Nakagawa 1, A Shimizu 1
PMCID: PMC1553261  PMID: 7648711

Abstract

Complement activation at a low temperature in vitro and cryoglobulinaemia are associated with hepatitis C virus (HCV) infection. The frequency of HCV antibody positivity determined in serum specimens that showed the cold-dependent activation of complement was 100%, whereas it was 48% among sera with cryoglobulin. On the other hand, the frequency of cold activation among HCV-infected sera was 41%, and that of cryoglobulin 48%. Cold activation was not found in any HCV- sera studied, whereas cryoglobulin was found at a frequency of 14% in HCV- sera. Cold activation was also absent among hepatitis B virus (HBV) S antigen or antibody-positive sera, except a few that were both HBV+ and HCV+. Rheumatoid factor was also frequently detected in sera with cold activation or cryoglobulin. Cold activation and cryoglobulin may be generated by common mechanisms in which a low avidity, low temperature-preferring antibody may function. In sera with cold activation, fine particles of immune complexes, which do not form precipitates, may activate the complement system. HCV is a unique virus that coexists with antibody in the serum, therefore the avidity of the antibody for the virus antigen may be low, and occasionally react only at a low temperature. This may be why the in vitro phenomenon related to immune complexes occurs specifically in HCV-infected sera.

Full text

PDF
284

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., Chung R. T., Kaplan L. M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992 Nov 19;327(21):1490–1495. doi: 10.1056/NEJM199211193272104. [DOI] [PubMed] [Google Scholar]
  2. Augener W., Grey H. M., Cooper N. R., Müller-Eberhard H. J. The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry. 1971 Nov;8(11):1011–1020. doi: 10.1016/0019-2791(71)90489-7. [DOI] [PubMed] [Google Scholar]
  3. Balázs V., Fröhlich M. M. Anticomplementary effect of cryoglobulinemic sera and isolated cryoglobulins. Am J Med Sci. 1966 Jan;251(1):51–56. doi: 10.1097/00000441-196601000-00009. [DOI] [PubMed] [Google Scholar]
  4. Casato M., Taliani G., Pucillo L. P., Goffredo F., Laganà B., Bonomo L. Cryoglobulinaemia and hepatitis C virus. Lancet. 1991 Apr 27;337(8748):1047–1048. doi: 10.1016/0140-6736(91)92715-e. [DOI] [PubMed] [Google Scholar]
  5. Durand J. M., Lefevre P., Harle J. R., Boucrat J., Vitviski L., Soubeyrand J. Cutaneous vasculitis and cryoglobulinaemia type II associated with hepatitis C virus infection. Lancet. 1991 Feb 23;337(8739):499–500. doi: 10.1016/0140-6736(91)93443-d. [DOI] [PubMed] [Google Scholar]
  6. Ferri C., Greco F., Longombardo G., Palla P., Moretti A., Marzo E., Fosella P. V., Pasero G., Bombardieri S. Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection. 1991 Nov-Dec;19(6):417–420. doi: 10.1007/BF01726453. [DOI] [PubMed] [Google Scholar]
  7. Hijikata M., Shimizu Y. K., Kato H., Iwamoto A., Shih J. W., Alter H. J., Purcell R. H., Yoshikura H. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol. 1993 Apr;67(4):1953–1958. doi: 10.1128/jvi.67.4.1953-1958.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Inai S., Kitamura H., Fujita T., Kojima J., Nagaki K. Differences between plasma and serum complement in patients with chronic liver disease. Clin Exp Immunol. 1976 Sep;25(3):403–409. [PMC free article] [PubMed] [Google Scholar]
  9. Kitamura H., Nagaki K., Inoshita K., Iida K., Inai S. The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis. Clin Exp Immunol. 1977 Jan;27(1):34–37. [PMC free article] [PubMed] [Google Scholar]
  10. Kondo M., Hosokawa K., Masuda M. Cold activation of complement i. presence of coagulation-related activator. J Immunol. 1976 Aug;117(2):486–490. [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Lunel F., Musset L., Cacoub P., Frangeul L., Cresta P., Perrin M., Grippon P., Hoang C., Valla D., Piette J. C. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 1994 May;106(5):1291–1300. doi: 10.1016/0016-5085(94)90022-1. [DOI] [PubMed] [Google Scholar]
  13. Marcellin P., Descamps V., Martinot-Peignoux M., Larzul D., Xu L., Boyer N., Pham B. N., Crickx B., Guillevin L., Belaich S. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology. 1993 Jan;104(1):272–277. doi: 10.1016/0016-5085(93)90862-7. [DOI] [PubMed] [Google Scholar]
  14. Mathews K. P., Mentyka R. A., Chambers S. L., Hugli T. E., Herschbach J. H., Zuraw B. L. Cold-dependent activation of complement: recognition, assessment, and mechanism. J Clin Immunol. 1992 Sep;12(5):362–370. doi: 10.1007/BF00920794. [DOI] [PubMed] [Google Scholar]
  15. Pascual M., Perrin L., Giostra E., Schifferli J. A. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis. 1990 Aug;162(2):569–570. doi: 10.1093/infdis/162.2.569. [DOI] [PubMed] [Google Scholar]
  16. Pechère-Bertschi A., Perrin L., de Saussure P., Widmann J. J., Giostra E., Schifferli J. A. Hepatitis C: a possible etiology for cryoglobulinaemia type II. Clin Exp Immunol. 1992 Sep;89(3):419–422. doi: 10.1111/j.1365-2249.1992.tb06973.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rother U., Rother K., Flad H. D., Miescher P. A. Bithermic complement activation in cryoglobulinaemic serum. Eur J Clin Invest. 1972 Jan;2(2):59–65. doi: 10.1111/j.1365-2362.1972.tb00570.x. [DOI] [PubMed] [Google Scholar]
  18. Sällberg M., Rudén U., Wahren B., Magnius L. O. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein. Clin Exp Immunol. 1993 Mar;91(3):489–494. doi: 10.1111/j.1365-2249.1993.tb05929.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ueda K., Nakajima H., Nakagawa T., Shimizu A. The association between hepatitis C virus infection and in vitro activation of the complement system. Ann Clin Biochem. 1993 Nov;30(Pt 6):565–569. doi: 10.1177/000456329303000607. [DOI] [PubMed] [Google Scholar]
  20. Yamaki M., Shimada T., Matsumoto C., Watanabe J., Nishioka K. Presence of lower temperature-dependent antibody with low avidity to C100-3 (HCV) antigen in voluntary blood donors. Jpn J Med Sci Biol. 1992 Feb;45(1):1–8. doi: 10.7883/yoken1952.45.1. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES